Lee JL - Search Results

1

Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure.

Park JH, Park I, Kim IH, Hur JY, Hwang I, Kim C, Kim HJ, Maeng CH, Park K, Lee MY, Lee HJ, Jung JY, Keam B, Park SH, Lee JL. Park JH, et al. Among authors: lee my, lee hj, lee jl. Curr Probl Cancer. 2022 Jun;46(3):100848. doi: 10.1016/j.currproblcancer.2022.100848. Epub 2022 Mar 8. Curr Probl Cancer. 2022. PMID: 35344842

2

Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.

Kim JH, Park I, Lee JL. Kim JH, et al. Among authors: lee jl. Cancer Chemother Pharmacol. 2016 Aug;78(2):325-32. doi: 10.1007/s00280-016-3093-8. Epub 2016 Jun 21. Cancer Chemother Pharmacol. 2016. PMID: 27324136

3

Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma.

Lee JY, Song C, Hong BS, Hong JH, Ahn H, Lee JL. Lee JY, et al. Among authors: lee jl. Cancer Chemother Pharmacol. 2017 Jan;79(1):173-180. doi: 10.1007/s00280-016-3222-4. Epub 2016 Dec 23. Cancer Chemother Pharmacol. 2017. PMID: 28011979

4

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05).

Choi YJ, Kim HS, Park SH, Kim BS, Kim KH, Lee HJ, Song HS, Shin DY, Lee HY, Kim HG, Lee KH, Lee JL, Park KH. Choi YJ, et al. Among authors: lee kh, lee hy, lee hj, lee jl. Cancer Res Treat. 2018 Oct;50(4):1252-1259. doi: 10.4143/crt.2017.438. Epub 2018 Jan 2. Cancer Res Treat. 2018. PMID: 29334610 Free PMC article. Clinical Trial.

5

A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non-clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus.

Park I, Lee SH, Lee JL. Park I, et al. Among authors: lee sh, lee jl. Clin Genitourin Cancer. 2018 Oct;16(5):e997-e1002. doi: 10.1016/j.clgc.2018.05.011. Epub 2018 May 23. Clin Genitourin Cancer. 2018. PMID: 29903415 Clinical Trial.

6

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients.

Choi Y, Keam B, Kim M, Yoon S, Kim D, Choi JG, Seo JY, Park I, Lee JL. Choi Y, et al. Among authors: lee jl. Cancer Res Treat. 2019 Oct;51(4):1549-1556. doi: 10.4143/crt.2019.086. Epub 2019 Mar 25. Cancer Res Treat. 2019. PMID: 30913859 Free PMC article.

7

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures.

Park I, Shim YS, Go H, Hong BS, Lee JL. Park I, et al. Among authors: lee jl. BMC Urol. 2019 Jun 10;19(1):51. doi: 10.1186/s12894-019-0484-2. BMC Urol. 2019. PMID: 31182090 Free PMC article.

8

A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.

Park I, Lee HJ, Bae WK, Yoon S, Lee JL. Park I, et al. Among authors: lee hj, lee jl. Invest New Drugs. 2019 Dec;37(6):1239-1246. doi: 10.1007/s10637-019-00817-0. Epub 2019 Jun 24. Invest New Drugs. 2019. PMID: 31231787 Clinical Trial.

9

Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16).

Park I, Kim BS, Lim HY, Kim HJ, Lee HJ, Choi YJ, Park KH, Lee KH, Yoon S, Hong B, Hong JH, Ahn H, Lee JL. Park I, et al. Among authors: lee kh, lee hj, lee jl. Eur J Cancer. 2020 Mar;127:183-190. doi: 10.1016/j.ejca.2019.08.034. Epub 2019 Oct 24. Eur J Cancer. 2020. PMID: 31668839 Clinical Trial.

10

Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors.

Hwang I, Park I, Yoon SK, Lee JL. Hwang I, et al. Among authors: lee jl. Clin Genitourin Cancer. 2020 Apr;18(2):e122-e133. doi: 10.1016/j.clgc.2019.09.009. Epub 2019 Sep 26. Clin Genitourin Cancer. 2020. PMID: 31837940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,063 results

Search Page